CA2288235A1 - Tumour suppressor gene dbccr1 at 9q32-33 - Google Patents

Tumour suppressor gene dbccr1 at 9q32-33 Download PDF

Info

Publication number
CA2288235A1
CA2288235A1 CA002288235A CA2288235A CA2288235A1 CA 2288235 A1 CA2288235 A1 CA 2288235A1 CA 002288235 A CA002288235 A CA 002288235A CA 2288235 A CA2288235 A CA 2288235A CA 2288235 A1 CA2288235 A1 CA 2288235A1
Authority
CA
Canada
Prior art keywords
nucleic acid
dbccr1
polypeptide
gene
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002288235A
Other languages
English (en)
French (fr)
Inventor
Margaret Knowles
Tomonori Habuchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Horizons Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2288235A1 publication Critical patent/CA2288235A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002288235A 1997-05-28 1998-05-26 Tumour suppressor gene dbccr1 at 9q32-33 Abandoned CA2288235A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9710995.3 1997-05-28
GBGB9710995.3A GB9710995D0 (en) 1997-05-28 1997-05-28 Tumour suppressor locus and gene at 9q32-33
PCT/GB1998/001515 WO1998054318A1 (en) 1997-05-28 1998-05-26 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33

Publications (1)

Publication Number Publication Date
CA2288235A1 true CA2288235A1 (en) 1998-12-03

Family

ID=10813172

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002288235A Abandoned CA2288235A1 (en) 1997-05-28 1998-05-26 Tumour suppressor gene dbccr1 at 9q32-33

Country Status (6)

Country Link
EP (1) EP0983355A1 (ja)
JP (1) JP2002511749A (ja)
AU (1) AU752701B2 (ja)
CA (1) CA2288235A1 (ja)
GB (1) GB9710995D0 (ja)
WO (1) WO1998054318A1 (ja)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9359646B2 (en) 2007-11-30 2016-06-07 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US9670551B2 (en) 2007-11-30 2017-06-06 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US9670552B2 (en) 2007-11-30 2017-06-06 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US9783857B2 (en) 2007-11-30 2017-10-10 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US9797017B2 (en) 2007-11-30 2017-10-24 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US10113203B2 (en) 2007-11-30 2018-10-30 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743909B2 (en) * 2002-06-17 2004-06-01 Isis Pharmaceuticals, Inc. Antisense modulation of PTPN12 expression
US5871917A (en) 1996-05-31 1999-02-16 North Shore University Hospital Research Corp. Identification of differentially methylated and mutated nucleic acids
US6617434B1 (en) 1996-05-31 2003-09-09 North Shore Long Island Jewish Research Institute Identificiaton of differentially methylated and mutated nucleic acids
WO2000001816A1 (en) * 1998-07-02 2000-01-13 Imperial Cancer Research Technology Limited TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
US6994991B1 (en) 1998-11-18 2006-02-07 North Shore - Long Island Jewish Research Institute Identification of differentially methylated multiple drug resistance loci
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
JP2008029293A (ja) * 2006-07-31 2008-02-14 Hisamitsu Pharmaceut Co Inc 癌の治療薬のスクリーニング方法及び癌の治療薬
EP2198042B1 (en) 2007-09-17 2016-11-02 MDxHealth SA Novel markers for bladder cancer detection
WO2018050844A1 (en) 2016-09-16 2018-03-22 Qiagen Gmbh Method for determining nucleic acid degradation in a sample in which at least two overlapping amplicons are produced and two probes are used in the method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756668A (en) * 1994-11-15 1998-05-26 The Johns Hopkins University School Of Medicine Hypermethylated in cancer polypeptide, HIC-1

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9359646B2 (en) 2007-11-30 2016-06-07 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US9365900B2 (en) 2007-11-30 2016-06-14 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US9670551B2 (en) 2007-11-30 2017-06-06 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US9670552B2 (en) 2007-11-30 2017-06-06 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US9783857B2 (en) 2007-11-30 2017-10-10 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US9797017B2 (en) 2007-11-30 2017-10-24 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene
US10113203B2 (en) 2007-11-30 2018-10-30 Genomictree, Inc. Diagnosis kit and chip for bladder cancer using bladder cancer specific methylation marker gene

Also Published As

Publication number Publication date
AU752701B2 (en) 2002-09-26
EP0983355A1 (en) 2000-03-08
WO1998054318A1 (en) 1998-12-03
JP2002511749A (ja) 2002-04-16
GB9710995D0 (en) 1997-07-23
AU7542598A (en) 1998-12-30

Similar Documents

Publication Publication Date Title
Habuchi et al. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32–q33
Nakamura et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t (7; 11)(p15; p15) in human myeloid leukaemia
EP1356030B1 (en) Runx3 gene showing anti-tumor activity and use thereof
Antonson et al. A novel human CCAAT/enhancer binding protein gene, C/EBPϵ, is expressed in cells of lymphoid and myeloid lineages and is localized on chromosome 14q11. 2 close to the T-cell receptor α/δ locus
AU707636C (en) Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
US6897018B1 (en) DLC-1 gene deleted in cancers
JP3399539B2 (ja) 乳癌および卵巣癌の素因の診断方法
AU752701B2 (en) Tumour suppressor gene DBCCR1 at 9q32-33
JPH06509701A (ja) ヒト結腸直腸癌において突然変異を起こしている遺伝子
US5681942A (en) Fanconi Anemia Type C gene
CA2115404A1 (en) Tumor suppressor gene merlin and uses thereof
Grötzinger et al. A highly amplified mouse gene is homologous to the human interferon-responsive Sp100 gene encoding an autoantigen associated with nuclear dots
WO2000001816A1 (en) TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
GB2307477A (en) Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof
EP0825198A1 (en) Plag gene family and tumorigenesis
US6548258B2 (en) Methods for diagnosing tuberous sclerosis by detecting mutation in the TSC-1 gene
EP0727486A2 (en) Tumour suppressor gene
US5556945A (en) Tumor suppressor gene
US6350867B1 (en) Compositions and methods for enhancing osseous growth, repair and regeneration
EP0920305B1 (en) Identification of genes altered in multiple myeloma
WO2002018592A1 (en) Tumour suppressor gene
WO1999043812A2 (en) Dlc-1 gene, a putative tumors suppressor gene
CA2259635A1 (en) Hmgi proteins in tumors and obesity
CN1403477A (zh) 具有促进3t3细胞转化功能的新的人蛋白及其编码序列
AU2001287348A1 (en) Tumour suppressor gene

Legal Events

Date Code Title Description
FZDE Dead